SIFROL Safety Questions, SIFROL Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about SIFROL. Our extensive database of SIFROL adverse events and SIFROL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about SIFROL

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




SIFROL Safety Reports

Total SIFROL reports: 55.
SIFROL FDA safety alerts: No.
Reported deaths: 5    Reported hospitalizations: 33.
Take SIFROL Side Effects Survey or Share Your SIFROL Story. Read More Here.

Consumer or non-health professional from reported SIFROL problem on Dec 14, 2006. Female patient, weighting 152.1 lb, was diagnosed with parkinson's disease and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: abasia, asthenia. SIFROL dosage: unknown. During the same period patient was treated with AMANTADINE. Patient recovered.

SIFROL problem was reported by a Physician from GERMANY on Jan 23, 2007. Male patient, weighting 198.4 lb, was diagnosed with restless legs syndrome and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: angina pectoris, blood pressure increased, hypertension, supraventricular tachycardia. SIFROL dosage: unknown. Patient recovered.

Physician from reported SIFROL problem on Jan 22, 2007. Male patient, weighting 286.6 lb, was diagnosed with restless legs syndrome and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: depression, irritability, obsessive thoughts, suicidal ideation. SIFROL dosage: unknown. During the same period patient was treated with AMLODIPINE, SIMVASTATIN, DIOVAN COMP, HJERTEMAGNYL. Patient was hospitalized. Patient recovered.

SIFROL problem was reported by a Physician from on Feb 20, 2007. Male patient, weighting 198.4 lb, was diagnosed with restless legs syndrome, colitis collagenous, adrenal insufficiency and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: angina pectoris, blood pressure increased, tachycardia. SIFROL dosage: unknown. During the same period patient was treated with MESALAZIN, BUDESONIDE, ASTONIN. Patient recovered.

Physician from GERMANY reported SIFROL problem on Feb 22, 2007. Female patient, 86 years of age, was diagnosed with parkinson's disease and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: cardiac failure. SIFROL dosage: unknown. Patient died on 01/01/2006.

SIFROL problem was reported by a Physician from GERMANY on Feb 20, 2007. Female patient, weighting 154.3 lb, was diagnosed with restless legs syndrome and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: anastomotic stenosis, extrasystoles, tachycardia. SIFROL dosage: unknown. During the same period patient was treated with TORSEMIDE, DREISAVIT N, BICANORM, PHOS EX, RENAGEL, INSUMAN BASAL, INSUMAN BASAL. Patient was hospitalized. Patient recovered.

Physician from reported SIFROL problem on Mar 01, 2007. Male patient, weighting 286.6 lb, was diagnosed with restless legs syndrome and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: depression, irritability, obsessive thoughts, suicidal ideation. SIFROL dosage: unknown. During the same period patient was treated with AMLODIPINE, SIMVASTATIN, DIOVAN COMP, HJERTEMAGNYL. Patient was hospitalized. Patient recovered.

SIFROL problem was reported by a Physician from on Mar 15, 2007. Male patient, 73 years of age, weighting 165.3 lb, was diagnosed with restless legs syndrome and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: angina pectoris, arteriospasm coronary. SIFROL dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from reported SIFROL problem on Mar 22, 2007. Male patient, weighting 198.4 lb, was diagnosed with restless legs syndrome and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: angina pectoris, arteriospasm coronary, chest pain, vascular anomaly. SIFROL dosage: unknown. Patient was hospitalized. Patient recovered.

SIFROL problem was reported by a Physician from GERMANY on Apr 10, 2007. Female patient, weighting 132.3 lb, was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: sopor, suicide attempt. SIFROL dosage: unknown. During the same period patient was treated with AMITRIPTLINE, AMPHETAMINE SULPHATE, MST, TRAMAL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported SIFROL problem on Apr 16, 2007. Female patient, weighting 172.0 lb, was diagnosed with restless legs syndrome and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: mental disorder, nausea. SIFROL dosage: unknown. During the same period patient was treated with PASPERTIN, BISOPRODOL FUMARATE, SIMVASTATIN, TRAMADOL. Patient was hospitalized. Patient recovered.

SIFROL problem was reported by a Physician from on Apr 17, 2007. Female patient, 67 years of age, weighting 132.3 lb, was diagnosed with restless legs syndrome and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: asthenia, blood glucose fluctuation, dizziness, hyperhidrosis, hypoglycaemia, nausea. SIFROL dosage: unknown. During the same period patient was treated with ALLOPURINOL, ASPIRIN, CODIOVANTE, CONCOR, TILIDIN. Patient recovered.

Physician from reported SIFROL problem on Apr 24, 2007. Female patient, weighting 149.9 lb, was diagnosed with restless legs syndrome and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: asthenia, blood glucose fluctuation, blood insulin decreased, dizziness, hyperhidrosis, hypoglycaemia, nausea. SIFROL dosage: unknown. During the same period patient was treated with ALLOPURINOL, ASPIRIN, CODIOVANTE, CONCOR, TILIDIN. Patient recovered.

SIFROL problem was reported by a Consumer or non-health professional from on Apr 24, 2007. Female patient, weighting 187.4 lb, was diagnosed with restless legs syndrome, extrapyramidal disorder and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: anxiety, dyspnoea, feeling abnormal, hypercholesterolaemia, hyperuricaemia, intercostal neuralgia, intervertebral disc displacement, magnesium deficiency. SIFROL dosage: unknown. During the same period patient was treated with MADOPAR LT, RESTEX RETARD, MADOPAR LT, VALORON, REQUIP, MAGNEROT CLASSIC. Patient was hospitalized and became disabled. Patient recovered.

Physician from reported SIFROL problem on May 09, 2007. Male patient, weighting 152.1 lb, was diagnosed with parkinsonism, tremor, depression and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: completed suicide. SIFROL dosage: unknown. During the same period patient was treated with LEVOBETA, MIRTAZAPINE. Patient died on 04/11/2007.

SIFROL problem was reported by a Physician from on May 03, 2007. Male patient, 68 years of age, was diagnosed with parkinson's disease and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, inappropriate antidiuretic hormone secretion. SIFROL dosage: unknown. During the same period patient was treated with IRBESARTAN, BUFLOMEDIL, PLAVIX, BISOPROLOL FUMARATE. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported SIFROL problem on May 14, 2007. Female patient, weighting 176.4 lb, was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: coma, convulsion, dry skin, miosis, pneumonia aspiration, respiratory failure, suicide attempt. SIFROL dosage: unknown. During the same period patient was treated with ASPIRIN, ATACAND. Patient recovered.

SIFROL problem was reported by a Physician from FRANCE on May 11, 2007. Male patient, 75 years of age, was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, disinhibition. SIFROL dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from reported SIFROL problem on May 29, 2007. Male patient, 75 years of age, was diagnosed with parkinson's disease, hypertension and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: blood electrolytes decreased. SIFROL dosage: unknown. During the same period patient was treated with MICARDIS, LEBOCAR. Patient was hospitalized. Patient recovered.

SIFROL problem was reported by a Consumer or non-health professional from on May 30, 2007. Female patient, weighting 198.4 lb, was diagnosed with parkinson's disease and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: cardiac failure, liver function test abnormal, oedema peripheral, sleep disorder, weight increased. SIFROL dosage: unknown. During the same period patient was treated with MIRAPEX, MADOPAR, LEVODOP, RAMIPRIL, FUROSEMIDE, PANTOPRAZOL, METAMIZOL. Patient was hospitalized and became disabled. Patient recovered.

Physician from ARGENTINA reported SIFROL problem on June 05, 2007. Male patient, 75 years of age, was diagnosed with parkinson's disease, hypertension and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: blood electrolytes decreased. SIFROL dosage: unknown. During the same period patient was treated with MICARDIS, LEBOCAR. Patient was hospitalized. Patient recovered.

SIFROL problem was reported by a Physician from GERMANY on June 06, 2007. Male patient, 66 years of age, was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: vasculitis. SIFROL dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported SIFROL problem on July 04, 2006. Male patient, 55 years of age, was diagnosed with parkinson's disease and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: aggression, euphoric mood, libido increased, pathological gambling. SIFROL dosage: unknown. During the same period patient was treated with STALEVO, SINEMET, CELANCE. Patient was hospitalized. Patient recovered.

SIFROL problem was reported by a Physician from on July 06, 2006. Male patient was diagnosed with parkinson's disease, coronary artery disease, hypercholesterolaemia, benign prostatic hyperplasia and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: erythema, feeling hot, oedema peripheral, pain in extremity, sudden onset of sleep, synovial rupture, varicose ulceration. SIFROL dosage: VARYING 0,18MG 3 X 3 AT MAXIMUM. During the same period patient was treated with MADOPAR DEPOT, ZOCOR, ELDEPRYL, OMNIC, FURESIS, CARDIOL. Patient was hospitalized. Patient recovered.

Physician from reported SIFROL problem on July 14, 2006. Male patient, 55 years of age, was diagnosed with restless legs syndrome, parkinson's disease and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. SIFROL dosage: unknown. Patient died on 01/01/2006.

SIFROL problem was reported by a Physician from on July 14, 2006. Male patient, 55 years of age, was diagnosed with restless legs syndrome, parkinson's disease and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. SIFROL dosage: unknown. Patient died on 01/01/2006.

Consumer or non-health professional from reported SIFROL problem on Aug 01, 2006. Female patient, weighting 152.1 lb, was diagnosed with parkinson's disease, thyroid disorder and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: blepharitis, constipation, dizziness postural, dyskinesia, hypoaesthesia, motor dysfunction, oedema peripheral. SIFROL dosage: unknown. During the same period patient was treated with STALEVO, THYROXIN, NACOM, ASPIRIN, SELECTOL. Patient was hospitalized. Patient recovered.

SIFROL problem was reported by a Physician from GERMANY on Aug 14, 2006. Female patient, 85 years of age, was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cholangitis, hepatic enzyme increased. SIFROL dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported SIFROL problem on Sept 07, 2006. Male patient, 62 years of age, was diagnosed with parkinson's disease and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, amnesia, derealisation, hallucination, obsessive thoughts, obsessive-compulsive disorder, pathological gambling, personality disorder. SIFROL dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

SIFROL problem was reported by a Physician from on July 24, 2006. Female patient, weighting 172.0 lb, was diagnosed with parkinson's disease, restlessness, dementia, cardiac failure, depression and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: confusional state, restlessness. SIFROL dosage: unknown. During the same period patient was treated with LEVODOPA, NOVODIGAL, SEROQUEL. Patient was hospitalized. Patient recovered.

Physician from reported SIFROL problem on Sept 19, 2006. Female patient, 72 years of age, was diagnosed with parkinson's disease and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: back pain, bone pain, chest discomfort, hyperkinesia, kyphosis, motor dysfunction. SIFROL dosage: unknown. During the same period patient was treated with MADOPAR, TRAMADOL, DICLOFENAC, MIRTAZAPINE. Patient was hospitalized. Patient recovered.

SIFROL problem was reported by a Physician from on Sept 19, 2006. Female patient, 72 years of age, was diagnosed with parkinson's disease and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: back pain, bone pain, chest discomfort, hyperkinesia, kyphosis, motor dysfunction. SIFROL dosage: unknown. During the same period patient was treated with MADOPAR, TRAMADOL, DICLOFENAC, MIRTAZAPINE. Patient was hospitalized. Patient recovered.

Physician from reported SIFROL problem on Oct 04, 2006. Female patient, 61 years of age, was diagnosed with parkinson's disease and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, dyspnoea, pharyngeal oedema, swollen tongue. SIFROL dosage: unknown. During the same period patient was treated with MADOPAR. Patient recovered.

SIFROL problem was reported by a Physician from on Nov 07, 2006. Male patient, weighting 191.8 lb, was diagnosed with restless legs syndrome and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: angina pectoris, anxiety, dizziness, hyperhidrosis. SIFROL dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported SIFROL problem on Oct 31, 2006. Male patient, weighting 200.6 lb, was diagnosed with restless legs syndrome, colitis collagenous, osteoarthritis and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: angina pectoris, arrhythmia, headache, hypertension, palpitations. SIFROL dosage: unknown. During the same period patient was treated with CLAVERSAL, ENTOCORT, TELTONAL. Patient recovered.

SIFROL problem was reported by a Physician from on Oct 26, 2006. Female patient, weighting 147.7 lb, was diagnosed with parkinson's disease, hypertension, coronary artery disease, angina pectoris and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: agitation, angina pectoris, arthralgia, intercostal neuralgia, myalgia. SIFROL dosage: unknown. During the same period patient was treated with ATACAND HCT, ATACAND HCT, AMANTADINE, PENTAERYTHRITOL TETRANITRATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported SIFROL problem on Nov 27, 2006. Female patient, 59 years of age, was diagnosed with restless legs syndrome, schizoaffective disorder and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: pleurothotonus. SIFROL dosage: unknown. During the same period patient was treated with ZYPREXA, FLUOXETINE, REMERON, VISKEN, DEMETRIN, DEPAKENE. Patient was hospitalized. Patient recovered.

SIFROL problem was reported by a Physician from GERMANY on Nov 20, 2006. Male patient, weighting 330.7 lb, was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: somnolence, suicide attempt. SIFROL dosage: unknown. During the same period patient was treated with AMITRIPTYLINE, MELLARIL, MELPERON, VALPROATE, SEROQUEL, TOPAMAX. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported SIFROL problem on Nov 27, 2006. Female patient, 59 years of age, was diagnosed with restless legs syndrome, schizoaffective disorder and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: pleurothotonus. SIFROL dosage: unknown. During the same period patient was treated with ZYPREXA, FLUOXETINE, REMERON, VISKEN, DEMETRIN, DEPAKENE. Patient was hospitalized. Patient recovered.

SIFROL problem was reported by a Consumer or non-health professional from on Dec 14, 2006. Female patient, weighting 152.1 lb, was diagnosed with parkinson's disease and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: abasia, asthenia. SIFROL dosage: unknown. During the same period patient was treated with AMANTADINE. Patient recovered.

Physician from GERMANY reported SIFROL problem on Dec 15, 2006. Male patient, 67 years of age, weighting 200.6 lb, was diagnosed with restless legs syndrome and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: angina pectoris, hypertension, tachyarrhythmia. SIFROL dosage: unknown. Patient recovered.

SIFROL problem was reported by a Physician from FRANCE on June 12, 2007. Female patient, weighting 172.0 lb, was diagnosed with parkinson's disease and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: gambling, hallucination, visual, nausea, oedema, sleep disorder, weight increased. SIFROL dosage: unknown. During the same period patient was treated with PERINDOPRIL ERBUMINE, MODOPAR, MANTADIX, LESCOL, LEVOTHYROXINE. Patient recovered.

Pharmacist from reported SIFROL problem on June 26, 2007. Female patient, weighting 152.1 lb, was diagnosed with parkinson's disease and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: fatigue, hypokinesia, vertigo. SIFROL dosage: unknown. During the same period patient was treated with SINEMET, CODOLIPRANE, SERESTA, LAROXYL, RIVOTRIL, COTAREG, TENORMIN. Patient recovered.

SIFROL problem was reported by a Physician from on June 25, 2007. Male patient, weighting 154.3 lb, was diagnosed with restless legs syndrome, cardiac failure, gout, arrhythmia, epilepsy and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: cardiac failure, oedema peripheral. SIFROL dosage: unknown. During the same period patient was treated with PERINDOPRIL ERBUMINE, BUMETANIDE, CARVEDILOL, COLCHICINE, ACENOCOUMAROL, FRISIUM, DEPAKENE, AMIODARONE. Patient was hospitalized. Patient died on 04/01/2007.

Physician from GERMANY reported SIFROL problem on July 02, 2007. Male patient, 68 years of age, was diagnosed with parkinson's disease and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: bundle branch block left, cardiac failure, dyspnoea exertional, ejection fraction decreased, left ventricular dysfunction. SIFROL dosage: unknown. Patient recovered.

SIFROL problem was reported by a Physician from GERMANY on July 13, 2007. Female patient, weighting 158.7 lb, was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: eye irritation, eye movement disorder, overdose, skin warm, somnolence, suicide attempt. SIFROL dosage: unknown. During the same period patient was treated with MADOPAR. Patient recovered.

Physician from GERMANY reported SIFROL problem on July 30, 2007. Male patient, weighting 165.3 lb, was diagnosed with central pontine myelinolysis, bartter's syndrome, pain, depression and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: cardiovascular insufficiency. SIFROL dosage: unknown. During the same period patient was treated with TEGRETOL, DOXEPIN, SULPIRIL. Patient was hospitalized. Patient recovered.

SIFROL problem was reported by a Physician from GERMANY on Aug 02, 2007. Male patient, weighting 143.3 lb, was diagnosed with parkinson's disease and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: bundle branch block left, cardiac failure, dyspnoea exertional, ejection fraction decreased, left ventricular dysfunction. SIFROL dosage: unknown. Patient recovered.

Consumer or non-health professional from GERMANY reported SIFROL problem on Aug 08, 2007. Male patient, weighting 160.9 lb, was diagnosed with parkinson's disease, hypercholesterolaemia and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: dysphagia, hordeolum, muscle spasms, myalgia. SIFROL dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, GODAMED. Patient recovered.

SIFROL problem was reported by a Physician from on Aug 16, 2007. Male patient, weighting 211.6 lb, was diagnosed with muscle spasms and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: dysarthria, listless, nightmare, pigmentation disorder, psoriasis, sleep talking, weight increased. SIFROL dosage: unknown. Patient recovered.

Physician from reported SIFROL problem on Aug 15, 2007. Female patient, 48 years of age, was diagnosed with restless legs syndrome and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: dizziness, overdose, somnolence. SIFROL dosage: unknown. During the same period patient was treated with IMOVANE. Patient was hospitalized. Patient recovered.

SIFROL problem was reported by a Physician from FRANCE on Aug 24, 2007. Male patient, 75 years of age, was diagnosed with parkinson's disease and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: renal failure acute. SIFROL dosage: unknown. During the same period patient was treated with MODOPAR. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported SIFROL problem on Sept 19, 2007. Male patient, 75 years of age, was diagnosed with parkinson's disease and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: light chain disease, renal failure acute. SIFROL dosage: unknown. During the same period patient was treated with MODOPAR. Patient was hospitalized. Patient recovered.

SIFROL problem was reported by a Physician from on Sept 21, 2007. Female patient, weighting 172.0 lb, was diagnosed with parkinson's disease, restlessness, dementia, cardiac failure, depression and was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: confusional state, restlessness. SIFROL dosage: unknown. During the same period patient was treated with LEVODOPA, NOVODIGAL, SEROQUEL. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported SIFROL problem on Sept 24, 2007. Male patient, child 12 years of age, was treated with SIFROL. After drug was administered, patient experienced the following problems/side effects: vomiting. SIFROL dosage: unknown. Patient recovered.

Ask Our Patient Community about SIFROL

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

Q
Quazepam
Quetiapine

QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase
(prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert
Ranexa (ranolazine)
Ranibizumab
Ranolazine
Rapamune (sirolimus)
Raptiva (efalizumab)
Rasagiline
RazadyneThis drug has as active FDA Safety Alert (galantamine)
Rebetol (ribavirin)
ReclastThis drug has as active FDA Safety Alert (zoledronic acid)
Refludan (lepirudin recombinant)
Relenza (zanamivir)
RelpaxThis drug has as active FDA Safety Alert (eletriptan)
RemeronThis drug has as active FDA Safety Alert (mirtazapine)
Renagel (sevelamer)
Rescula (unoprostone isopropyl)
Restoril (temazepam)
Revatio (sildenafil)
Revlimid (lenalidomide)
Reyataz (atazanavir sulfate)
Ribasphere (ribavarin ribasphere)
Ribavarin ribasphere
Rifapentine
Rifaximin
RisedronateThis drug has as active FDA Safety Alert
Risperdal (risperidone)
Risperidone
Ritalin (methylphenidate)
Ritonavir
RituxanThis drug has as active FDA Safety Alert
RituximabThis drug has as active FDA Safety Alert
Rivastigmine tartrate
RizatriptanThis drug has as active FDA Safety Alert
RocephinThis drug has as active FDA Safety Alert (ceftriaxone)
Rofecoxib